IDEXX LABORATORIES INC /DE (IDXX) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000874716 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $1.22B | $338.4M | $4.27 | Filing |
| Mar 31, 2026 | May 5, 2026 | $1.14B | $278.4M | $3.47 | Filing |
| Dec 31, 2025 | Feb 2, 2026 | $1.09B | $248.2M | $3.09 | Filing |
| Sep 30, 2025 | Nov 3, 2025 | $1.11B | $274.6M | $3.40 | Filing |
| Jun 30, 2025 | Aug 4, 2025 | $1.11B | $294.0M | $3.63 | Filing |
| Mar 31, 2025 | May 1, 2025 | $998.4M | $242.7M | $2.96 | Filing |
| Dec 31, 2024 | Feb 3, 2025 | $954.3M | $216.1M | $2.62 | Filing |
| Sep 30, 2024 | Oct 31, 2024 | $975.5M | $232.8M | $2.80 | Filing |
What would IDEXX LABORATORIES INC /DE have to report for its valuation to change?
At $560.36, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 27.5% a year, to $47.90. On that path the next quarter needs diluted EPS near $4.33, against $3.40 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 27.5% | 27.5% |
| EPS needed in final year | $47.90 | $47.90 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. IDXX goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.